Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

University of Oxford’s Jenner Institute appoints first Bvlgari Scholars

Awards and Appointments General

Bvlgari and the University of Oxford’s Jenner Institute announce the next stage of their pledge to build a pandemic-free future by awarding the inaugural Bvlgari Scholarships.

Bvlgari Scholars Rebecca Makinson and Cameron Bissett outside the Big Data Institute Building © John Cairns
Bvlgari Scholars Rebecca Makinson and Cameron Bissett

Following the announcement in June of a new philanthropic relationship between Bvlgari and the University of Oxford, Bvlgari’s donation in support of DPhil students in vaccine research benefits two exceptional students, appointed as the first cohort of Bvlgari Scholars. The Jenner Institute welcomes students Cameron Bissett and Rebecca Makinson this month for the start of their DPhil courses, after demonstrating remarkable academic potential and merit in the field of vaccine-related immunology.

Oxford’s Professor of Vaccinology Sarah Gilbert, who joined Bvlgari CEO Jean-Christophe Babin in June to announce the brand’s donation during a live webinar, said: ‘We are very grateful to Bvlgari who have enabled Cameron and Rebecca to focus on their vital research free from financial worry. I hope these students are the first of many more future cohorts of Bvlgari Scholars.’

Reaching headlines across the globe for their vaccine candidate for COVID-19, Oxford’s Jenner Institute is a world-leading vaccine development group, designing, manufacturing and testing many novel vaccine technologies.

The full story is available on The Jenner Institute website

Similar stories

Any type of hormonal contraceptive may increase risk of breast cancer

An analysis of data by researchers at the Nuffield Department of Population Health’s Cancer Epidemiology Unit has shown that use of progestogen-only hormonal contraceptives is associated with a 20-30% higher risk of breast cancer. The results are published in PLOS Medicine.

Viewing self-harm images on the internet and in social media usually causes harm, according to new review

Clinical researchers have reviewed the international research evidence regarding the impact of viewing images of self-harm on the internet and in social media.

Can humans hibernate?

Illuminating new TEDx Talk from Professor of Sleep Physiology Vladyslav Vyazovskiy

Athena Swan Gold Award success for Nuffield Department of Primary Care Health Sciences

The award reflects the Department’s commitment to representation, progression and success for all. It acknowledges the innovative policies and practices developed across the department and the detailed action plans for improvement.

RECOVERY trial team awarded MRC Impact Prize for Outstanding Team Impact

The Medical Research Council Prize Committee has awarded the RECOVERY trial team the MRC Impact Prize 2022 for Outstanding Team Impact.

Professor Sir Chris Whitty brings greater understanding of epidemics to Oxford

Chief Medical Officer of England Professor Sir Chris Whitty KCB FMedSci delivers the Sherrington Prize Lecture: Public Understanding of Science to an audience of Oxford staff and students.